Fig. 2From: Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drugMolecular interaction of Crizotinib drug with 2WGJ, 3ZBF and 2XP2. In 2WGJ, primary interaction occurs in the ATP binding sites are Glu2027, Met2029, in 3ZBF, found in Pro1158, Met 11,600 and 2XP2 protein, Glu1197, Met1199 amino acid residues. These hydrogen bond interactions are displayed as green color in the imageBack to article page